from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3292/-

LFCtreatmentdescriptionclass of inhibitor

-0.142

Amikacinug/mL Amikacintranslation

-1.014

Cap5-10ug/mL Capreomycintranslation

-1.236

Rox10-50 ug/mL Roxithromycintranslation

-0.113

SM2-5 ug/mL Streptomycintranslation

0.121

Tet5-10 ug/mL Tetracyclinetranslation

0.158

Rif0.2-5ug/mL Rifampicintranscription

-0.548

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.729

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.084

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.487

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.219

Clofazimine10-13 ug/mL Clofaziminerespiration

0.069

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.678

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.341

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.237

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.015

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.436

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.760

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.151

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.165

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.663

KCN5-20 ug/mL Potassium cyaniderespiration

-0.688

NaN30.2-2 mM Sodium aziderespiration

-0.157

Nigericin50 uM Nigericinrespiration

-0.440

TRC10-150 ug/mL Triclosanrespiration

-1.830

TRZ10-25 ug/mL Thioridazinerespiration

-0.164

Valinomycin0.5-10 uM Valinomycinrespiration

0.945

ZnSO42 mM ZnSO4respiration

0.645

menadione6-10 ug/mL Menadionerespiration

-0.079

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.012

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.022

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.352

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.716

NRP_1Non-replicating persistence stage 1dosRassociated

0.064

Amp0.2mg/mL AmpicillincellWall

0.332

Cephalexin20-100 ug/mL CephalexincellWall

0.117

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.209

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.064

EMB10-20 ug/mL EthambutolcellWall

0.520

Eta12-40 ug/mL EthionamidecellWall

0.425

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.011

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.403

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.075

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.662

BZA0.12 mg/mL BenzamidearomaticAmides

0.656

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.896

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.873

H2O24 mM hydrogen peroxideDNAdamaging

-0.108

Levo10 ug/mL LevofloxacinDNAdamaging

-0.056

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.119

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.008

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.288

UVUV-irradiationDNAdamaging

-0.616

ARP41-4 ug/mL Antitubercular compound ARP4?

0.042

Antimycin12.5-50 ug/mL Antimycin A?

-0.247

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.533

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.350

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.163

PA8240.2-2 ug/mL PA-824?

2.133

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.190

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.505

Verapamil50 uM Verapamil?

-0.362

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.377

methoxatin10-20 ug/mL Methoxatin?